Context: Oral squamous cell carcinoma (OSCC) constitutes to majority of oral malignancies, with established etiological links to tobacco use and alcohol consumption. In recent years, human papillomavirus (HPV), especially HPV-16 and HPV-18, has emerged as a potential contributory factor in the pathogenesis of OSCC. Aim: This study aimed to detect HPV types 16 and 18 in OSCC patients using the real-time polymerase chain reaction (RT-PCR) and to evaluate the correlation between the presence of HPV and clinical staging, histopathological grading, and tobacco usage. Materials and Methods: A total of 40 individuals were enrolled in the study which comprised of 30 histopathologically confirmed OSCC patients (Group A) and 10 healthy age- and gender-matched controls (Group B). Oral brush biopsy samples were collected and analyzed using TaqMan-based RT-PCR targeting 14 HPV genotypes. Statistical analyses were performed to assess the correlations with clinical and demographic parameters. Results: HPV-16 was detected in 13.3% (4/30) of OSCC patients, while all control samples were negative for both HPV-16 and HPV-18. HPV-16 positivity was significantly associated with Stage II–III OSCC ( P = 0.014) and tobacco smoking ( P = 0.007), with 67% of HPV-positive patients reporting smoked tobacco use. Although HPV-16 was more frequent in moderately and poorly differentiated tumors, this association was not statistically significant ( P = 0.195). HPV-18 was not detected in any sample. Conclusion: The findings suggest that HPV-16 may act as a co-factor in OSCC, especially in older male smokers with advanced disease, highlighting the need for larger multicentric studies to clarify its etiological and prognostic role.
No takes yet. Share an insight, caveat, or question.
Mhapuskar et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: